Clinical Trial Update: Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial results for Palifermin to reduce oral mucositis in patients with locally advanced head and neck cancer. The results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma
• Oral Mucositis
• Oral Stomatitis

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Mucositis, Solid Tumors | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15